Atlas Trials

Intrahepatic and Peripheral Responses to Imdusiran (AB-729) in Chronic Hepatitis B

Clinical trial NCT06154278 · RECRUITING

Trial details

NCT number
NCT06154278
Sponsor
University of Maryland, Baltimore
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Hepatitis B
Start date
2024-07-25
Primary completion
2026-12-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.